SUBSCRIBE
SUBSCRIBE
News   Drug Development

Neurosearch A/S Shares Fall; Drug Trials Stopped

October 19, 2005 | 
1 min read
COPENHAGEN -(Dow Jones)- Shares in NeuroSearch A/S (NEUR.KO), one of Denmark's pioneer biotech companies, plummeted 46% Wednesday as a partner declined to proceed with trials of one of the company's most promising drugs.
Clinical research Phase 3
Boehringer Ingelheim
MORE ON THIS TOPIC
Businessman holding a dart aiming at the target - business targeting, aiming, focus concept. Art collage.
Cancer
AbbVie’s T cell engager delivers survival benefit in Phase 3 multiple myeloma study
September 4, 2026
 · 
2 min read
 · 
Tristan Manalac
Lung organ anatomy symbol for health and medical illustrations. vector, illustration.
Lung cancer
RevMed’s newly approved Rasonque could ‘hold up’ in non-small cell lung cancer
September 3, 2026
 · 
2 min read
 · 
Heather McKenzie
Gilded female hand holding a golden crown with dark chalkboard background. Royalty, succes and high quality concept.
Lung cancer
Summit, Akeso’s ivonescimab bests Merck’s Keytruda in China trial—again
September 3, 2026
 · 
2 min read
 · 
Annalee Armstrong
Market failure, recession. Businessman falling into the trap. vector
Rare diseases
Ultragenyx’s ‘high-risk’ Angelman bet fails, cratering stock and forcing strategic review
September 3, 2026
 · 
2 min read
 · 
Tristan Manalac